Dr Stephen Antonioli Jennings, MD | |
2050a Second St Se, Kirtland Afb, NM 87117-5522 | |
(505) 846-2426 | |
Not Available |
Full Name | Dr Stephen Antonioli Jennings |
---|---|
Gender | Male |
Speciality | Surgery |
Location | 2050a Second St Se, Kirtland Afb, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003888793 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Stephen Antonioli Jennings, MD 2050a Second St Se, Kirtland Afb, NM 87117-5522 Ph: (505) 846-2426 | Dr Stephen Antonioli Jennings, MD 2050a Second St Se, Kirtland Afb, NM 87117-5522 Ph: (505) 846-2426 |
News Archive
Scientists at the University of York have made a significant step forward in isolating the cause of Parkinson's disease in younger adults.
Researchers from the Johns Hopkins Children's Center say a group of drugs known as "atypical antipsychotics" that are commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance, a condition that increases the risk of developing Type 2 diabetes and heart disease later in life.
Galderma, a global healthcare company focused on skin health, announced today that it has received U.S. Food and Drug Administration approval to market Restylane Lyft for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21.
Of all the groups that try to quit smoking, it seems hardest for those who suffer from anxiety and depression. The health effects are jarring: People with mental illness or substance use disorders die about five years earlier than those without these disorders and many of those deaths are caused by smoking cigarettes, according to the Centers for Disease Control and Prevention.
› Verified 2 days ago